According to Editas Medicine 's latest financial reports the company's current EPS (TTM) is -$4.70. In 2022 the company made an earnings per share (EPS) of -$5.10 a decrease over its 2021 EPS that were of -$4.53.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$4.44 | -12.98% |
2022 | -$5.10 | 12.63% |
2021 | -$4.53 | 43.22% |
2020 | -$3.16 | -26.02% |
2019 | -$4.28 | 15.45% |
2018 | -$3.70 | -21.81% |
2017 | -$4.74 | -1.65% |
2016 | -$4.82 | -29.19% |
2015 | -$6.80 |